ArticleBrain and behavior2025

Predictors of Radiological and Clinical Disease Reactivation in Multiple Sclerosis Patients After Cessation of Natalizumab (Tysabri).

Roba El Zibaoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.